FDA adverse Event Problem Codes: standardizing the classification of device and patient problems associated with...

Area of Science:

• Medical device surveillance
• Public health informatics
• Regulatory science

Background:

• Medical device surveillance programs face challenges due to the wide array of devices and potential for adverse events.
• Existing Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) Event Problem Codes lacked structured controls, leading to inconsistencies.
• The ad-hoc nature of past code development resulted in ambiguous and duplicative concepts within the coding system.

Purpose of the Study:

• To update and improve the FDA's medical device Event Problem Codes for better surveillance.
• To establish a more consistent and controlled system for coding medical device adverse events.
• To enhance the utility of the code set for internal FDA analysis and as a global standard.

Main Methods:

• A Memorandum of Understanding (MOU) between the FDA and National Cancer Institute (NCI) in 2004 facilitated terminology development.
• The CDRH's Office of Surveillance and Biometrics (OSB) collaborated with NCI Enterprise Vocabulary Service (EVS) to streamline codes.
• Patient and Device Problem Codes were integrated into the NCI Thesaurus and Meta-Thesaurus, with enhancements for code selection and analysis.

Main Results:

• The initiative streamlined the Patient and Device Problem Codes.
• Enhancements were made to improve code selection accuracy.
• The updated system aims to improve adverse event report analysis for medical devices.

Conclusions:

• A consistent, well-defined code set is crucial for understanding medical device adverse events.
• The FDA initiative improved the structure and control of the Event Problem Codes.
• Enhanced analysis tools can better identify device safety trends and mitigate adverse event effects.